PubRank

W Koornstra

Author PubWeight™ 14.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge. AIDS 1995 1.34
2 The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol 1993 1.10
3 Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Hum Retroviruses 1994 1.00
4 Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med 1994 0.98
5 The major polypeptides of the murine-mammary-tumor virus isolated by plant-lectin affinity chromatography. Eur J Biochem 1977 0.97
6 Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees. AIDS 2001 0.95
7 Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy. J Virol 2000 0.93
8 Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. Immunol Lett 1996 0.92
9 Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination. J Gen Virol 1995 0.92
10 Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques. J Med Virol 2007 0.87
11 The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques. J Gen Virol 2000 0.85
12 Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines. J Med Primatol 1992 0.83
13 Localization of murine mammary tumor virus polypeptides on the surface of tumor cells. Eur J Cancer 1979 0.82
14 Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines. Vaccine 1994 0.79
15 Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)). J Virol 2001 0.76
16 Lack of evidence for non-virion cell surface antigens on virally-induced murine mammary tumor cell. Eur J Cancer 1980 0.75
17 The purification and characterization of a major glycoprotein of the murine mammary tumor virus. Anal Biochem 1979 0.75
18 Expression of MuMTV antigens in rabbits and rats infected with MuMTV. Virology 1979 0.75